Cargando…
Coinage Metal Compounds With 4-Methoxy-Diphenylphosphane Benzoate Ligand Inhibit Female Cancer Cell Growth
In the continuous effort to find new metal-based compounds as alternatives to platinum-related anticancer drugs, 11(th) group metal phosphane compounds have been thoroughly taken into consideration. Tris-arylphosphane metal derivatives have been extensively considered as heteroleptic metal compounds...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325969/ https://www.ncbi.nlm.nih.gov/pubmed/35910727 http://dx.doi.org/10.3389/fchem.2022.924584 |
_version_ | 1784757172735836160 |
---|---|
author | Luciani, Lorenzo Galassi, Rossana Wang, Junbiao Marchini, Cristina Cogo, Alessia Di Paolo, Maria Luisa Dalla Via, Lisa |
author_facet | Luciani, Lorenzo Galassi, Rossana Wang, Junbiao Marchini, Cristina Cogo, Alessia Di Paolo, Maria Luisa Dalla Via, Lisa |
author_sort | Luciani, Lorenzo |
collection | PubMed |
description | In the continuous effort to find new metal-based compounds as alternatives to platinum-related anticancer drugs, 11(th) group metal phosphane compounds have been thoroughly taken into consideration. Tris-arylphosphane metal derivatives have been extensively considered as heteroleptic metal compounds exhibiting remarkable cytotoxic activities. Functional groups in the aryl moieties modulate the activity reinforcing or eliminating it. Previous works have highlighted that the presence of hydrophilic groups in the phosphane ligands, such as COOH or OH, hampers the anticancer activity of gold azolate/PPh(3) compounds. To increase the polarity of the triarylphosphane ligand without affecting the activity, we considered the preparation of esters starting from the 4-diphenylphosphane-benzoic acid. The resulting phosphanes are poorer donators than the PPh(3), leading to poly-phosphane M(I) compounds, and they exhibit intense emissive properties. A homologous series of L(3)MX-type compounds (where M = Au and X = Cl, M = Cu and X = BF(4), and M = Ag and X = PF(6)) were obtained with the 4-methoxy-diphenylphosphane benzoate. The homologous metal compounds have been characterized by analytical and spectroscopic methods and, remarkably, their formation was associated with high frequencies of (31)P NMR chemical shift variations (5–35 ppm in CDCl(3)). The new complexes and the ligand were evaluated on sensitive and cisplatin-resistant human tumor cell lines. The ligand is ineffective on cells while the complexes exert a notable antiproliferative effect. The homologous series of the L(3)MX complexes were able to significantly reduce the cell viability of human triple-negative breast cancer cells (MDA-MB-231), representing the most aggressive subtype of breast cancer, and of ovarian carcinoma (A2780). Among these coinage metal compounds, L(3)AgPF(6) results the most interesting, showing the lowest GI(50) values in all cell lines. Interestingly, this silver complex is more cytotoxic than cisplatin, taken as reference drug. The investigation of the mechanism of action of L(3)AgPF(6) in A2780 cells highlighted the induction of the apoptotic pathway, the depolarization of the mitochondrial inner membrane, and a significant accumulation in cells. |
format | Online Article Text |
id | pubmed-9325969 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93259692022-07-28 Coinage Metal Compounds With 4-Methoxy-Diphenylphosphane Benzoate Ligand Inhibit Female Cancer Cell Growth Luciani, Lorenzo Galassi, Rossana Wang, Junbiao Marchini, Cristina Cogo, Alessia Di Paolo, Maria Luisa Dalla Via, Lisa Front Chem Chemistry In the continuous effort to find new metal-based compounds as alternatives to platinum-related anticancer drugs, 11(th) group metal phosphane compounds have been thoroughly taken into consideration. Tris-arylphosphane metal derivatives have been extensively considered as heteroleptic metal compounds exhibiting remarkable cytotoxic activities. Functional groups in the aryl moieties modulate the activity reinforcing or eliminating it. Previous works have highlighted that the presence of hydrophilic groups in the phosphane ligands, such as COOH or OH, hampers the anticancer activity of gold azolate/PPh(3) compounds. To increase the polarity of the triarylphosphane ligand without affecting the activity, we considered the preparation of esters starting from the 4-diphenylphosphane-benzoic acid. The resulting phosphanes are poorer donators than the PPh(3), leading to poly-phosphane M(I) compounds, and they exhibit intense emissive properties. A homologous series of L(3)MX-type compounds (where M = Au and X = Cl, M = Cu and X = BF(4), and M = Ag and X = PF(6)) were obtained with the 4-methoxy-diphenylphosphane benzoate. The homologous metal compounds have been characterized by analytical and spectroscopic methods and, remarkably, their formation was associated with high frequencies of (31)P NMR chemical shift variations (5–35 ppm in CDCl(3)). The new complexes and the ligand were evaluated on sensitive and cisplatin-resistant human tumor cell lines. The ligand is ineffective on cells while the complexes exert a notable antiproliferative effect. The homologous series of the L(3)MX complexes were able to significantly reduce the cell viability of human triple-negative breast cancer cells (MDA-MB-231), representing the most aggressive subtype of breast cancer, and of ovarian carcinoma (A2780). Among these coinage metal compounds, L(3)AgPF(6) results the most interesting, showing the lowest GI(50) values in all cell lines. Interestingly, this silver complex is more cytotoxic than cisplatin, taken as reference drug. The investigation of the mechanism of action of L(3)AgPF(6) in A2780 cells highlighted the induction of the apoptotic pathway, the depolarization of the mitochondrial inner membrane, and a significant accumulation in cells. Frontiers Media S.A. 2022-07-13 /pmc/articles/PMC9325969/ /pubmed/35910727 http://dx.doi.org/10.3389/fchem.2022.924584 Text en Copyright © 2022 Luciani, Galassi, Wang, Marchini, Cogo, Di Paolo and Dalla Via. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Chemistry Luciani, Lorenzo Galassi, Rossana Wang, Junbiao Marchini, Cristina Cogo, Alessia Di Paolo, Maria Luisa Dalla Via, Lisa Coinage Metal Compounds With 4-Methoxy-Diphenylphosphane Benzoate Ligand Inhibit Female Cancer Cell Growth |
title | Coinage Metal Compounds With 4-Methoxy-Diphenylphosphane Benzoate Ligand Inhibit Female Cancer Cell Growth |
title_full | Coinage Metal Compounds With 4-Methoxy-Diphenylphosphane Benzoate Ligand Inhibit Female Cancer Cell Growth |
title_fullStr | Coinage Metal Compounds With 4-Methoxy-Diphenylphosphane Benzoate Ligand Inhibit Female Cancer Cell Growth |
title_full_unstemmed | Coinage Metal Compounds With 4-Methoxy-Diphenylphosphane Benzoate Ligand Inhibit Female Cancer Cell Growth |
title_short | Coinage Metal Compounds With 4-Methoxy-Diphenylphosphane Benzoate Ligand Inhibit Female Cancer Cell Growth |
title_sort | coinage metal compounds with 4-methoxy-diphenylphosphane benzoate ligand inhibit female cancer cell growth |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325969/ https://www.ncbi.nlm.nih.gov/pubmed/35910727 http://dx.doi.org/10.3389/fchem.2022.924584 |
work_keys_str_mv | AT lucianilorenzo coinagemetalcompoundswith4methoxydiphenylphosphanebenzoateligandinhibitfemalecancercellgrowth AT galassirossana coinagemetalcompoundswith4methoxydiphenylphosphanebenzoateligandinhibitfemalecancercellgrowth AT wangjunbiao coinagemetalcompoundswith4methoxydiphenylphosphanebenzoateligandinhibitfemalecancercellgrowth AT marchinicristina coinagemetalcompoundswith4methoxydiphenylphosphanebenzoateligandinhibitfemalecancercellgrowth AT cogoalessia coinagemetalcompoundswith4methoxydiphenylphosphanebenzoateligandinhibitfemalecancercellgrowth AT dipaolomarialuisa coinagemetalcompoundswith4methoxydiphenylphosphanebenzoateligandinhibitfemalecancercellgrowth AT dallavialisa coinagemetalcompoundswith4methoxydiphenylphosphanebenzoateligandinhibitfemalecancercellgrowth |